Bone and soft tissue sarcomas represent only about 2% of all malignancies; however, their treatment – with the goal of curing the patient while preserving the functionality of the affected body part – can, unlike other malignancies, only be successful with therapy concepts devised by interdisciplinary teams. This volume provides an extensive up-to-date overview of the specific diagnostics and current treatment standards of these rare entities, presenting the various limb-sparing modalities for patients with bone and soft tissue sarcomas with special regard to innovative reconstructive options. The evaluation of quality of life based on validated scores and the individual methods of coping with the illness through creative artistic projects are also acknowledged and integrated in the whole concept.

During the past decade, the prognosis of bone and soft tissue tumors has improved considerably. This progress has not only been due to improved therapeutics and diagnostic methods but also due to a team approach now universally adopted. Comparison of results, possible today, were hampered in the past by lack of a clinically relevant staging system and definitive treatment proto cols. The complexity of the therapeutic management of bone tumors re quires a constant exposure to tumors, highly skilled diagnostic tech niques, and specialized expertise. It is therefore not surprising to learn that small and medium-sized hospitals embarking on the diagnosis and treatment of bone and soft tissue tumors are generally less success ful than better equipped major centers. This fact has already been recognized by most physicians and surgeons who now refer their patients to specialized oncologic centers. Nevertheless, they all have to know the present state of the art. This symposium was therefore mostly addressed to them. This international symposium, organized by the Division of Orthopaedic Surgery, University of Ottawa, and cosponsored by the Association des Chirurgiens Orthopedistes du Quebec, was held in Ottawa from May 12-14, 1983. Each of the 40 presentations clearly demonstrates that disregard for proper staging before initiation of treatment and omission of a clearly defined treatment protocol is definitely unacceptable in view of the knowledge we have acquired.

PLEASE NOTE: Text has been accidentally deleted from page 54 of this book. Please refer to the corrigenda (PDF file) posted on the Stylus Publishing web site or email [email protected] for an updated, printable page. ****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Soft Tissue and Bone Tumours is the third volume in the 5th edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. This volume will be of particular interest to pathologists, oncologists, surgeons, and epidemiologists who manage or research soft tissue and bone tumours. Sections are included on all recognized neoplasms of the soft tissue and bone, as well as on genetic tumour syndromes affecting these sites. Since the previous edition, there have been changes based on recent molecular and genetic information, with impact on clinical practice.

Offers fingertip access to the diagnostic tools necessary for the definitive diagnosis and treatment of the most common musculo-skeletal disorders found in adults and children.

During the past decade, the prognosis of bone and soft tissue tumors has improved considerably. This progress has not only been due to improved therapeutics and diagnostic methods but also due to a team approach now universally adopted. Comparison of results, possible today, were hampered in the past by lack of a clinically relevant staging system and definitive treatment proto cols. The complexity of the therapeutic management of bone tumors re quires a constant exposure to tumors, highly skilled diagnostic tech niques, and specialized expertise. It is therefore not surprising to learn that small and medium-sized hospitals embarking on the diagnosis and treatment of bone and soft tissue tumors are generally less success ful than better equipped major centers. This fact has already been recognized by most physicians and surgeons who now refer their patients to specialized oncologic centers. Nevertheless, they all have to know the present state of the art. This symposium was therefore mostly addressed to them. This international symposium, organized by the Division of Orthopaedic Surgery, University of Ottawa, and cosponsored by the Association des Chirurgiens Orthopedistes du Quebec, was held in Ottawa from May 12-14, 1983. Each of the 40 presentations clearly demonstrates that disregard for proper staging before initiation of treatment and omission of a clearly defined treatment protocol is definitely unacceptable in view of the knowledge we have acquired.

This open access book focuses on diagnostic and interventional imaging of the chest, breast, heart, and vessels. It consists of a remarkable collection of contributions authored by internationally respected experts, featuring the most recent diagnostic developments and technological advances with a highly didactical approach. The chapters are disease-oriented and cover all the relevant imaging modalities, including standard radiography, CT, nuclear medicine with PET, ultrasound and magnetic resonance imaging, as well as imaging-guided interventions. As such, it presents a comprehensive review of current knowledge on imaging of the heart and chest, as well as thoracic interventions and a selection of "hot topics". The book is intended for radiologists, however, it is also of interest to clinicians in oncology, cardiology, and pulmonology.

This text presents an overview of the basic science and principles of high dose chemotherapy, current state-of-the-art techniques and future developments such as gene therapy. The main section of the book is disease-based, setting the scientific principles within a clinical context and reviewing the application of high dose therapy in specific diseases. Additional sections discuss supportive care and long-term complications. High Dose Chemotherapy is directed at hematologists, clinical and medical oncologists in training or with an interest, rather than direct involvement, in the field.

Only with the advent of computed tomography and magnetic resonance imaging have radiologists become familiar with this uncommon pathology. The emphasis here is on MRI, as it guarantees the most accurate diagnosis of soft tissue tumours. Because of their rarity, multi-centric studies are necessary to collect statistically relevant numbers of these tumours and so assess the value of new imaging techniques in their detection, staging, grading, tissue characterisation, and post-treatment follow-up. This is a reflection of the work of a prestigious European study group of more than 30 such co-investigators - including experts on medical imaging - who collected more than 800 documented and histologically proven cases of soft tissue tumours. For each tumour type, 10-12 cases are shown, supported by 3-4 photos. Unsurpassed in its collection of case studies.

The must-have book for candidates preparing for the oral component of the FRCS (Tr and Orth).